Company intelligence / Profile preview

Casdin Advisors

New York, New York, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Casdin Capital is a premier investment firm specializing in the life sciences and healthcare sectors. Founded in 2011 by Eli Casdin, the firm manages a concentrated portfolio of both public and private companies that are driving innovation in genomics, molecular diagnostics, and synthetic biology. Casdin is recognized for its deep technical expertise and long-term investment approach, providing capital and strategic guidance to companies across all stages of development. The firm plays a pivotal role in the biotech ecosystem by identifying and supporting disruptive technologies that aim to transform patient care and healthcare efficiency. Headquartered in New York, Casdin Capital remains a key influencer in the genomic revolution and the broader life sciences investment landscape.

Industry: Investors

Beyond the preview

Go deeper on Casdin Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Casdin Advisors.

Explore the full profile